167 related articles for article (PubMed ID: 9735128)
1. Guidelines for the use of radio-iodine, thyroid hormone, and treatment of metastatic disease in patients with differentiated thyroid cancer.
Paloyan E; Walker RP; Lawrence AM
Surg Oncol Clin N Am; 1998 Oct; 7(4):665-80. PubMed ID: 9735128
[TBL] [Abstract][Full Text] [Related]
2. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
Seabold JE; Gurll N; Schurrer ME; Aktay R; Kirchner PT
J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
[TBL] [Abstract][Full Text] [Related]
4. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
5. Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma.
Nakanishi K; Kikumori T; Miyajima N; Takano Y; Noda S; Takeuchi D; Iwano S; Kodera Y
Clin Nucl Med; 2018 Jul; 43(7):482-485. PubMed ID: 29688947
[TBL] [Abstract][Full Text] [Related]
6. Whole-body Tc-99m sestamibi scintigraphy in the follow-up of differentiated thyroid carcinoma.
Almeida-Filho P; Ravizzini GC; Almeida C; Borges-Neto S
Clin Nucl Med; 2000 Jun; 25(6):443-6. PubMed ID: 10836693
[TBL] [Abstract][Full Text] [Related]
7. Esophageal diverticulum presenting as metastatic thyroid mass on iodine-131 scintigraphy.
Rashid K; Johns W; Chasse K; Walker M; Gupta SM
Clin Nucl Med; 2006 Jul; 31(7):405-8. PubMed ID: 16785810
[No Abstract] [Full Text] [Related]
8. False positive and false negative thyroid 99mTc-sestamibi scintigraphy in the same patient.
Gholamrezanezhad A; Muckle M; Ahmadzadehfar H; Biersack HJ; Ezziddin S
Nuklearmedizin; 2010; 49(6):N69-70. PubMed ID: 21140034
[No Abstract] [Full Text] [Related]
9. Radio-guided surgery for non-131I-avid thyroid cancer.
Rubello D; Pelizzo MR; Casara D; Piotto A; Toniato A; Fig L; Gross M
Thyroid; 2006 Nov; 16(11):1105-11. PubMed ID: 17123337
[TBL] [Abstract][Full Text] [Related]
10. Results of external beam radiotherapy in patients with well differentiated thyroid carcinoma.
Lin JD; Tsang NM; Huang MJ; Weng HF
Jpn J Clin Oncol; 1997 Aug; 27(4):244-7. PubMed ID: 9379512
[TBL] [Abstract][Full Text] [Related]
11. [Radioguided cervical lymphadenectomy in one case of recurrence of differentiated thyroid microcarcinoma].
Frontado-Morales L; Martinez-Sanchis B; Sanchez-Vaño R; Caballero-Calabuig E; Abreu-Sanchez P; Reyes-Ojeda MD
Rev Esp Med Nucl Imagen Mol; 2012; 31(2):106-7. PubMed ID: 21820215
[No Abstract] [Full Text] [Related]
12. [Use of serum thyroglobulin determination in the follow-up of differentiated carcinomas of the thyroid].
Secades Ariz I; Pérez Piqueras JL; Labanda Tejedor P; Cordero Peinado J
An Med Interna; 1988 Sep; 5(9):439-43. PubMed ID: 2856622
[No Abstract] [Full Text] [Related]
13. [PET-FDG in thyroid cancer with high thyroglobulin levels and negative 131-I scan. A case report].
Ortega F; Maldonado A; Marañes P; Montz R; Pérez-Castejón MJ; Melgarejo M; Ruiz JA; Carreras JL
Rev Esp Med Nucl; 1999; 18(1):50-4. PubMed ID: 10074219
[TBL] [Abstract][Full Text] [Related]
14. Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma.
Muratet JP; Giraud P; Daver A; Minier JF; Gamelin E; Larra F
J Nucl Med; 1997 Sep; 38(9):1362-8. PubMed ID: 9293788
[TBL] [Abstract][Full Text] [Related]
15. Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma.
Muratet JP; Daver A; Minier JF; Larra F
J Nucl Med; 1998 Sep; 39(9):1546-50. PubMed ID: 9744340
[TBL] [Abstract][Full Text] [Related]
16. Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.
Elisei R; Schlumberger M; Driedger A; Reiners C; Kloos RT; Sherman SI; Haugen B; Corone C; Molinaro E; Grasso L; Leboulleux S; Rachinsky I; Luster M; Lassmann M; Busaidy NL; Wahl RL; Pacini F; Cho SY; Magner J; Pinchera A; Ladenson PW
J Clin Endocrinol Metab; 2009 Nov; 94(11):4171-9. PubMed ID: 19850694
[TBL] [Abstract][Full Text] [Related]
17. Stunning effects after a diagnostic dose of iodine-131.
Kao CH; Yen TC
Nuklearmedizin; 1998 Jan; 37(1):30-2. PubMed ID: 9467167
[TBL] [Abstract][Full Text] [Related]
18. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.
Ladenson PW; Braverman LE; Mazzaferri EL; Brucker-Davis F; Cooper DS; Garber JR; Wondisford FE; Davies TF; DeGroot LJ; Daniels GH; Ross DS; Weintraub BD
N Engl J Med; 1997 Sep; 337(13):888-96. PubMed ID: 9302303
[TBL] [Abstract][Full Text] [Related]
19. Contemporary management of papillary carcinoma of the thyroid gland.
Rosenbaum MA; McHenry CR
Expert Rev Anticancer Ther; 2009 Mar; 9(3):317-29. PubMed ID: 19275510
[TBL] [Abstract][Full Text] [Related]
20. [Role of the nuclear medicine in the treatment of thyroid carcinoma].
Börner W; Reiners C
Med Klin; 1980 Jan; 75(2):80-7. PubMed ID: 7374606
[No Abstract] [Full Text] [Related]
[Next] [New Search]